Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IBTA
stocks logo

IBTA

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
83.23M
-15.4%
-0.023
-101.01%
74.39M
-12.04%
-0.330
-1751.1%
78.11M
-9.21%
-0.209
-360.76%
Estimates Revision
The market is revising Upward the revenue expectations for Ibotta, Inc. (IBTA) for FY2025, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by -13.20%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.11%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-13.20%
In Past 3 Month
Wall Street analysts forecast IBTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBTA is 28.00 USD with a low forecast of 22.00 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast IBTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBTA is 28.00 USD with a low forecast of 22.00 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
3 Hold
2 Sell
Hold
Current: 23.880
sliders
Low
22.00
Averages
28.00
High
33.00
Current: 23.880
sliders
Low
22.00
Averages
28.00
High
33.00
Evercore ISI
In Line
downgrade
$38 -> $32
2025-11-13
Reason
Evercore ISI
Price Target
$38 -> $32
2025-11-13
downgrade
In Line
Reason
Evercore ISI lowered the firm's price target on Ibotta to $32 from $38 and keeps an In Line rating on the shares following Q3 results that the firm calls "a mixed bag." Revenue and EBITDA estimates for 2026 have been cut by 11% and 16%, respectively, reflecting ongoing concerns, notes the analyst, who adds that "transformation takes time."
Goldman Sachs
Sell
downgrade
$26 -> $23
2025-11-13
Reason
Goldman Sachs
Price Target
$26 -> $23
2025-11-13
downgrade
Sell
Reason
Goldman Sachs lowered the firm's price target on Ibotta to $23 from $26 and keeps a Sell rating on the shares. The "LiveLift" platform transition remains a work in progress, the analyst tells investors in a research note.
BofA
Curtis Nagle
Underperform
downgrade
$24 -> $22
2025-11-13
Reason
BofA
Curtis Nagle
Price Target
$24 -> $22
2025-11-13
downgrade
Underperform
Reason
BofA analyst Curtis Nagle lowered the firm's price target on Ibotta to $22 from $24 and keeps an Underperform rating on the shares. Following Q3 results and Q4 guidance, the firm lowers its 2026 revenue forecast by 6% and EBITDA by 17%, cuts its 2027 revenue view by 4% and EBITDA by 9%, and rolls forward its valuation framework to 2027.
Goldman Sachs
Hold -> Sell
downgrade
$30 -> $26
2025-10-14
Reason
Goldman Sachs
Price Target
$30 -> $26
2025-10-14
downgrade
Hold -> Sell
Reason
Goldman Sachs downgraded Ibotta to Sell from Hold with a price target of $26, down from $30.
Citizens JMP
Outperform -> Market Perform
downgrade
$NULL
2025-08-14
Reason
Citizens JMP
Price Target
$NULL
2025-08-14
downgrade
Outperform -> Market Perform
Reason
Citizens JMP downgraded Ibotta to Market Perform from Outperform without a price target following the Q2 report. The firm says the company's product investments are taking more time than expected as it restructures its sales force. Citizens materially lowered 2026 revenue and EBITDA estimates and believes Ibotta has limited revenue visibility in the near term.
BofA
Neutral -> Underperform
downgrade
$24
2025-08-14
Reason
BofA
Price Target
$24
2025-08-14
downgrade
Neutral -> Underperform
Reason
BofA downgraded Ibotta to Underperform from Neutral with a $24 price target.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Ibotta Inc (IBTA.N) is -39.27, compared to its 5-year average forward P/E of -4.89. For a more detailed relative valuation and DCF analysis to assess Ibotta Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-4.89
Current PE
-39.27
Overvalued PE
61.88
Undervalued PE
-71.67

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
13.92
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
18.46
Undervalued EV/EBITDA
9.39

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.29
Current PS
0.00
Overvalued PS
5.85
Undervalued PS
2.73
AI Stock Picker
AI Stock Picker

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Financial AI Agent
Financial AI Agent

IBTA News & Events

Events Timeline

(ET)
2025-11-12
16:14:24
Ibotta projects Q4 revenue between $80M and $85M, with consensus at $84.3M
select
2025-11-12
16:13:45
Ibotta announces Q3 adjusted EPS of 56 cents, surpassing estimates of 34 cents.
select
2025-09-30 (ET)
2025-09-30
14:30:46
Ibotta and Circana Form Strategic Alliance
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
7.0
12-01Globenewswire
Crucial Update for Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK), Fortrea Holdings, Inc. (NASDAQ: FTRE), Ibotta, Inc. (NYSE: IBTA), and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Looking into Claims for You

  • Cytokinetics Investigation: Grabar Law Office is investigating claims against Cytokinetics, Inc. for potential breaches of fiduciary duties by its officers and directors, following allegations of misleading statements regarding the FDA's review process for their drug aficamten, which harmed shareholders.

  • Fortrea Holdings Investigation: Shareholders of Fortrea Holdings, Inc. are being investigated for claims of misleading statements about the company's financial prospects and operations, which allegedly inflated their earnings targets and misrepresented the viability of their business model.

  • Ibotta Investigation: Grabar Law Office is looking into claims against Ibotta, Inc. for misleading investors during its IPO regarding the risks associated with its contract with Kroger, which was at-will and could be terminated without notice, potentially impacting the company's revenue.

  • WEBTOON Entertainment Investigation: A class action lawsuit against WEBTOON Entertainment Inc. has survived a motion to dismiss, with allegations that the company misrepresented its Monthly Active Users and failed to disclose adverse trends affecting its business prior to its IPO.

[object Object]
Preview
5.0
11-29TipRanks
Cathie Wood Celebrates Black Friday by Purchasing Bitcoin ETF and Selling GitLab Shares

  • Cathie Wood's Trading Activity: On November 28, Cathie Wood made significant trades in ARK Invest ETFs, including fresh investments in crypto through the ARK 21Shares Bitcoin ETF, despite a shortened trading week due to Thanksgiving.

  • GitLab Share Sales: ARK Invest continued to reduce its position in GitLab, selling 208,528 shares worth approximately $8.46 million, following a previous sale of 646,911 shares valued at about $26.8 million.

  • Focus on Digital Assets: While trimming positions in software stocks, ARK increased its investment in digital assets, purchasing 70,125 shares of the ARK 21Shares Bitcoin ETF for around $425,000.

  • Market Trends: The ongoing interest in Bitcoin and digital assets suggests that ARK is positioning itself to capitalize on the growing attention from firms in the crypto space.

[object Object]
Preview
5.0
11-25TipRanks
Cathie Wood Reinforces Investment in This AI Stock, Reduces Stake in GitLab (GTLB) Once More

  • ARK Invest's New Trades: On November 24, ARK Invest reported significant buying activity in CoreWeave, CRISPR Therapeutics, and crypto-related stocks, while reducing its stakes in GitLab, Reddit, Iridium Communications, and Ibotta.

  • CoreWeave Investment: ARK made a notable purchase of 437,345 shares of CoreWeave, valued at approximately $31.3 million, continuing a trend of consistent buying despite the stock's recent decline of about 44%.

  • Biotech and Crypto Exposure: The firm also increased its investment in CRISPR Therapeutics by acquiring 42,404 shares worth around $2.1 million, and added to its crypto holdings with purchases in Circle Internet and Bullish.

  • GitLab Position Reduction: ARK further decreased its position in GitLab, selling 646,911 shares valued at about $26.8 million, indicating a strategic move to gradually exit the stock.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Ibotta Inc (IBTA) stock price today?

The current price of IBTA is 23.88 USD — it has decreased -1.08 % in the last trading day.

arrow icon

What is Ibotta Inc (IBTA)'s business?

Ibotta, Inc. is a technology company that allows consumer packaged goods (CPG) brands to deliver digital promotions to consumers through a single network called the Ibotta Performance Network (IPN). The Company provides promotional services to publishers, retailers, and advertisers through the IPN, which includes its direct-to-consumer mobile, Web, and browser extension properties and its network of third-party publisher properties. The Company offers products in non-discretionary categories, such as grocery, and also works with general merchandise manufacturers in categories such as toys, clothing, beauty, electronics, pets, home goods, and sporting goods. Its technology platform uses an artificial intelligence (AI)-enabled offer engine that is designed to match and distribute the right offer to the right consumer at the right time. The Company also hosts offers on direct-to-consumer properties, which include the Ibotta-branded cashback mobile app, Website, and browser extension.

arrow icon

What is the price predicton of IBTA Stock?

Wall Street analysts forecast IBTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IBTA is 28.00 USD with a low forecast of 22.00 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Ibotta Inc (IBTA)'s revenue for the last quarter?

Ibotta Inc revenue for the last quarter amounts to 83.26M USD, decreased -15.58 % YoY.

arrow icon

What is Ibotta Inc (IBTA)'s earnings per share (EPS) for the last quarter?

Ibotta Inc. EPS for the last quarter amounts to 0.05 USD, decreased -90.20 % YoY.

arrow icon

What changes have occurred in the market's expectations for Ibotta Inc (IBTA)'s fundamentals?

The market is revising Upward the revenue expectations for Ibotta, Inc. (IBTA) for FY2025, with the revenue forecasts being adjusted by 0.11% over the past three months. During the same period, the stock price has changed by -13.20%.
arrow icon

How many employees does Ibotta Inc (IBTA). have?

Ibotta Inc (IBTA) has 886 emplpoyees as of December 05 2025.

arrow icon

What is Ibotta Inc (IBTA) market cap?

Today IBTA has the market capitalization of 634.80M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free